LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.

Photo from archive.org

Fabry disease (FD) is an X-linked lysosomal storage disorder (LSD) caused by mutations of the α-galactosidase A gene. The lysosomal enzyme α -galactosidase A (GLA) mediates the hydrolysis of the… Click to show full abstract

Fabry disease (FD) is an X-linked lysosomal storage disorder (LSD) caused by mutations of the α-galactosidase A gene. The lysosomal enzyme α -galactosidase A (GLA) mediates the hydrolysis of the terminal α -galactosyl moiety from globotriaosylceramide (Gb3). An enzymatic defect leads to the

Keywords: replacement therapy; therapy antidrug; effects enzyme; enzyme replacement; fabry disease; antidrug antibodies

Journal Title: Journal of the American Society of Nephrology : JASN
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.